$5.9 Billion Immuno-Oncology Assays Market Opportunities to 2024: Breakdown by Product, Technology, Indication and Application - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Feb 20, 2019--The “Immuno-Oncology Assays Market by Product, Technology, Indication, Application - Global Forecast to 2024” report has been added to ResearchAndMarkets.com’s offering.
The immuno-oncology assays market is expected to grow from USD 2.9 billion in 2018 to USD 5.9 billion by 2024, at a CAGR of 12.7% during the forecast period.
The immuno-oncology assays market is driven primarily by factors such as the increasing adoption of targeted therapy over traditional therapy and the increasing demand for mAbs. However, the high cost of immunotherapy treatment and the high attrition rate in the product development cycle are the major factors that are expected to restrain the growth of this market during the forecast period.
The lung cancer segment is expected to grow at the highest CAGR during the forecast period
Based on indication, the immuno-oncology assays market is segmented into lung cancer, colorectal cancer, melanoma, bladder cancer, and other cancers. The lung cancer segment is expected to be the fastest-growing segment during the forecast period, as major players are focusing on immuno-oncology research for lung cancer owing to its increasing incidence.
Asia Pacific projected to grow at the highest CAGR during the forecast period
The Asia Pacific is projected to record the highest growth rate during the forecast period. Factors such as the growing number of CROs in the region, increasing awareness about early detection of cancer, and the shift of manufacturers’ and suppliers’ focus from developed economies to emerging economies, such as India and China are driving the growth of this regional segment.
The immuno-oncology assays market comprises major providers such as Thermo Fischer Scientific (US), Roche Diagnostics (Switzerland), Agilent Technologies (US), and Illumina (US). The study includes an in-depth competitive analysis of these key players in the immuno-oncology assays market, along with their company profiles, recent developments, and key market strategies.
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Covered for the Study
2 Research Methodology
2.1 Primary Data
2.1.1 Key Data From Primary Sources
2.1.2 Key Industry Insights
2.2 Secondary Data
2.2.1 Key Data From Secondary Sources
2.3 Market Size Estimation
2.4 Market Breakdown and Data Triangulation
2.4.1 Assumptions for the Study
3 Executive Summary
4 Premium Insights
4.1 Immuno-Oncology Assays: Market Overview
4.2 North America: Immuno-Oncology Assays Market, By Product and Country (2018)
4.3 Immuno-Oncology Assays Market, By Application (2018 vs 2024)
4.4 Immuno-Oncology Assays Market, By Technology (2018 vs 2024)
4.5 Geographical Snapshot of the Immuno-Oncology Assays Market
5 Market Overview
5.2 Market Dynamics
22.214.171.124 Rising Incidence of Cancer and Increasing Adoption of Targeted Therapy
126.96.36.199 Unfavorable Regulatory and Reimbursement Scenario
188.8.131.52 High Amount of Capital Investments and Low Benefit-Cost Ratio
184.108.40.206 Companion Diagnostics
6 Immuno-Oncology Assays Market, By Product
6.2.1 Consumables Segment Will Continue to Dominate the Immuno-Oncology Assays Market During the Forecast Period
6.3.1 The Need to Deliver Accurate and Timely Analysis of Diagnostic Tests has Resulted in the Increased Adoption of Software
7 Immuno-Oncology Assays Market, By Technology
7.2.1 Emergence of Advanced PCR Technologies to Support Market Growth
7.3.1 Immunoassays Have the Potential to Reduce Cancer Mortality Rate by Facilitating the Diagnosis of Cancer in the Early Stage
7.4.1 NGS Segment to Register the Highest Growth Rate During the Forecast Period
7.5 Flow Cytometry
7.5.1 Flow Cytometry Plays a Critical Role in Clinical Research Studies
7.6 Other Technologies
8 Immuno-Oncology Assays Market, By Indication
8.2 Lung Cancer
8.2.1 Increasing R&D Activities on Lung Immuno-Oncology Assays is a Key Market Driver
8.3 Colorectal Cancer
8.3.1 High Success Rate of Immuno-Oncology Assays in CRC Treatment Decisions to Drive Market Growth
8.4.1 Growing Cases of Melanoma to Drive Market Growth
8.5 Bladder Cancer
8.5.1 Bladder Cancer Segment to Witness Slower Growth Owing to the Limited Adoption of Immuno-Oncology Assays
8.6 Other Cancers
9 Immuno-Oncology Assays Market, By Application
9.2 Research Applications
9.2.1 Rising Prominence of Biomarker-Based Drug Development and Clinical Trials to Drive the Research Applications Market
9.3 Clinical Diagnostics
9.3.1 Benefits of Immuno-Oncology Assays are Driving Its Adoption in Clinical Diagnostics
10 Immuno-Oncology Assays Market, By Region
10.2 North America
10.2.1.1 Increasing Demand for Immunotherapy Medicine forms a Key Driver of Market Growth in the US
10.2.2.1 High Burden of Cancer to Drive the Demand for Immuno-Oncology Assays
10.3.1 Rising Focus on Biomarker Development in Several EU Countries to Support Market Growth
10.4 Asia Pacific
10.4.1 Increasing Demand for Better Healthcare Services in Developing Economies will Contribute to Market Growth
10.5 Rest of the World
11 Competitive Landscape
11.2 Vendor Benchmarking
11.3 Competitive Leadership Mapping
11.3.1 Visionary Leaders
11.3.3 Dynamic Differentiators
11.3.4 Emerging Companies
11.4 Market Ranking Analysis, 2017
11.5 Competitive Situation and Trends
11.5.2 Product Launches
12 Company Profiles
12.1 Thermo Fisher Scientific Inc.
12.2 Roche Diagnostics
12.3 Agilent Technologies Inc.
12.4 Illumina Inc.
12.5 Nanostring Technologies Inc.
12.6 Sartorius AG
12.7 Foundation Medicine
12.8 HTG Molecular Diagnostics Inc.
For more information about this report visit https://www.researchandmarkets.com/research/ckgqd6/5_9_billion?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20190220005567/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Oncology Drugs ,Oncology
INDUSTRY KEYWORD: HEALTH ONCOLOGY PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 02/20/2019 08:59 AM/DISC: 02/20/2019 08:59 AM